Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Similar Journals
Journal Cover
The Lancet Oncology
Journal Prestige (SJR): 16.085
Citation Impact (citeScore): 10
Number of Followers: 269  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 1470-2045 - ISSN (Online) 1474-5488
Published by Elsevier Homepage  [3286 journals]
  • Clinical and molecular characteristics of HER2-low-positive breast cancer:
           pooled analysis of individual patient data from four prospective,
           neoadjuvant clinical trials

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 9 July 2021Source: The Lancet OncologyAuthor(s): Carsten Denkert, Fenja Seither, Andreas Schneeweiss, Theresa Link, Jens-Uwe Blohmer, Marianne Just, Pauline Wimberger, Almuth Forberger, Hans Tesch, Christian Jackisch, Sabine Schmatloch, Mattea Reinisch, Erich F Solomayer, Wolfgang D Schmitt, Claus Hanusch, Peter A Fasching, Kristina Lübbe, Christine Solbach, Jens Huober, Kerstin Rhiem
       
  • Perioperative or postoperative adjuvant oxaliplatin with S-1 versus
           adjuvant oxaliplatin with capecitabine in patients with locally advanced
           gastric or gastro-oesophageal junction adenocarcinoma undergoing D2
           gastrectomy (RESOLVE): an open-label, superiority and non-inferiority,
           phase 3 randomised controlled trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 9 July 2021Source: The Lancet OncologyAuthor(s): Xiaotian Zhang, Han Liang, Ziyu Li, Yingwei Xue, Yanong Wang, Zhiwei Zhou, Jiren Yu, Zhaode Bu, Lin Chen, Yian Du, Xinbao Wang, Aiwen Wu, Guoli Li, Xiangqian Su, Gang Xiao, Ming Cui, Dan Wu, Li Chen, Xiaojiang Wu, Yanbing Zhou
       
  • HER2: a never ending story

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 9 July 2021Source: The Lancet OncologyAuthor(s): Maria Vittoria Dieci, Federica Miglietta
       
  • New radiation health standard required for deep space travel

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 8 July 2021Source: The Lancet OncologyAuthor(s): Elizabeth Gourd
       
  • ESMO World Congress on Gastrointestinal Cancer 2021

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 8 July 2021Source: The Lancet OncologyAuthor(s): Katherine Gourd
       
  • Serbia faces bleak cancer situation

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 8 July 2021Source: The Lancet OncologyAuthor(s): Manjulika Das
       
  • Lebanon faces critical shortage of drugs

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 8 July 2021Source: The Lancet OncologyAuthor(s): Manjulika Das
       
  • Nomograms to predict outcomes after 177Lu-PSMA therapy in men with
           metastatic castration-resistant prostate cancer: an international,
           multicentre, retrospective study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 8 July 2021Source: The Lancet OncologyAuthor(s): Andrei Gafita, Jeremie Calais, Tristan R Grogan, Boris Hadaschik, Hui Wang, Manuel Weber, Shahneen Sandhu, Clemens Kratochwil, Rouzbeh Esfandiari, Robert Tauber, Anna Zeldin, Hendrik Rathke, Wesley R Armstrong, Andrew Robertson, Pan Thin, Calogero D'Alessandria, Matthew B Rettig, Ebrahim S Delpassand, Uwe Haberkorn, David Elashoff
       
  • Correction to Lancet Oncol 2021; published online July 1.
           https://doi.org/10.1016/S1470-2045(21)00389-2

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 6 July 2021Source: The Lancet OncologyAuthor(s):
       
  • Stereotactic body radiotherapy plus pembrolizumab and trametinib versus
           stereotactic body radiotherapy plus gemcitabine for locally recurrent
           pancreatic cancer after surgical resection: an open-label, randomised,
           controlled, phase 2 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 5 July 2021Source: The Lancet OncologyAuthor(s): Xiaofei Zhu, Yangsen Cao, Wenyu Liu, Xiaoping Ju, Xianzhi Zhao, Lingong Jiang, Yusheng Ye, Gang Jin, Huojun Zhang
       
  • Cabozantinib for radioiodine-refractory differentiated thyroid cancer
           (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3
           trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 5 July 2021Source: The Lancet OncologyAuthor(s): Marcia S Brose, Bruce Robinson, Steven I Sherman, Jolanta Krajewska, Chia-Chi Lin, Fernanda Vaisman, Ana O Hoff, Erika Hitre, Daniel W Bowles, Jorge Hernando, Leonardo Faoro, Kamalika Banerjee, Jennifer W Oliver, Bhumsuk Keam, Jaume Capdevila
       
  • Effect of general practitioner-led versus surgeon-led colon cancer
           survivorship care, with or without eHealth support, on quality of life (I
           CARE): an interim analysis of 1-year results of a randomised, controlled
           trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 2 July 2021Source: The Lancet OncologyAuthor(s): Julien A M Vos, Laura A M Duineveld, Thijs Wieldraaijer, Jan Wind, Wim B Busschers, Edanur Sert, Pieter J Tanis, Irma M Verdonck-de Leeuw, Henk C P M van Weert, Kristel M van Asselt, I CARE study group
       
  • Who should manage post-treatment care for patients with colon cancer:
           surgeons or general practitioners'

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 2 July 2021Source: The Lancet OncologyAuthor(s): Eva Angenete
       
  • The challenges of cancer care for the LQBTQ+ community

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 1 July 2021Source: The Lancet OncologyAuthor(s): Talha Khan Burki
       
  • Richter's transformation in the heart

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Andrea Marra, Francesco Adamo, Stefano Baldoni, Maria Elena Laurenti, Michele Giansanti, Stefano Pasquino, Barbara Bigerna, Daniele Sorcini, Arianna Stella, Valerio Guarente, Roberto Limongello, Vincenzo Perriello, Giovanni Martino, Stefano Ascani, Brunangelo Falini, Paolo Sportoletti
       
  • Evidence-based approaches for the management of side-effects of adjuvant
           endocrine therapy in patients with breast cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Maria Alice Franzoi, Elisa Agostinetto, Marta Perachino, Lucia Del Mastro, Evandro de Azambuja, Ines Vaz-Luis, Ann H Partridge, Matteo Lambertini
       
  • Intensifying neoadjuvant treatment in locally advanced rectal cancer
           – Authors' reply

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Thierry Conroy, Florence Castan, Sophie Gourgou, Frédéric Marchal, Christophe Borg
       
  • Intensifying neoadjuvant treatment in locally advanced rectal cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Swapnil Patel, Akhil Kapoor
       
  • Adjuvant therapy in stage IIIA melanoma - Authors' reply

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Alexander M M Eggermont, Stefan Suciu, Caroline Robert
       
  • Adjuvant therapy in stage IIIA melanoma

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Elif Hindié
       
  • Partial breast irradiation with intraoperative radiotherapy in the ELIOT
           trial – Authors' reply

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Roberto Orecchia, Patrick Maisonneuve, Maria Cristina Leonardi
       
  • Partial breast irradiation with intraoperative radiotherapy in the ELIOT
           trial

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Gustavo Nader Marta, Icro Meattini
       
  • Partial breast irradiation with intraoperative radiotherapy in the ELIOT
           trial

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Jayant S Vaidya, Max Bulsara, Samuele Massarut, Elena Sperk, Frederik Wenz, Jeffrey S Tobias, TARGIT-A trial authors
       
  • Partial breast irradiation with intraoperative radiotherapy in the ELIOT
           trial

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Orit Kaidar-Person, Philip Poortmans
       
  • Partial breast irradiation with intraoperative radiotherapy in the ELIOT
           trial

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Gerd Fastner, Roland Reitsamer, Felix Sedlmayer
       
  • Patient selection for immunotherapy in head and neck cancer –
           Authors' reply

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Nancy Y Lee, Robert L Ferris, Steven De Beukelaer, Ezra Cohen
       
  • Patient selection for immunotherapy in head and neck cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Pierluigi Bonomo, Ester Orlandi, Paolo Bossi
       
  • Second-line FOLFOX chemotherapy for advanced biliary tract cancer –
           Authors' reply

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Angela Lamarca, Daniel H Palmer, Harpreet Singh Wasan, Paul J Ross, Yuk Ting Ma, Arvind Arora, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Kinnari Patel, Alan Anthoney, Anthony Maraveyas, Tim Iveson, Justin S Waters, Claire Hobbs, Safia Barber, W David Ryder, John Ramage, Linda M Davies, John A Bridgewater
       
  • Second-line FOLFOX chemotherapy for advanced biliary tract cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Raja Pramanik, Atul Sharma, Akash Kumar
       
  • Second-line FOLFOX chemotherapy for advanced biliary tract cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Tiffany Foo, Ganessan Kichenadasse, Amitesh Roy, Christos S Karapetis
       
  • Second-line FOLFOX chemotherapy for advanced biliary tract cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Giovanni Brandi, Giorgio Frega, Alessandro Rizzo
       
  • Second-line FOLFOX chemotherapy for advanced biliary tract cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Fangqiang Wei
       
  • Real-time fluorescence imaging for cancer surgery: a pathologist's
           perspective – Authors' reply

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Lorraine J Lauwerends, Pieter B A A van Driel, Senada Koljenović, Alexander L Vahrmeijer, Stijn Keereweer
       
  • Real-time fluorescence imaging for cancer surgery: a pathologist's
           perspective

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Sachin C Sarode, Gargi S Sarode
       
  • Biomedicine and the soul of medicine: optimising the balance

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Gary Rodin, Christian Ntizimira, Richard Sullivan
       
  • Endocrinopathies induced by immune checkpoint inhibitors: the need for
           clear endocrine diagnosis

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): Ruth Percik, James Larkin, Daniel L Morganstein
       
  • CAR T-cell therapy for solid tumours

    • Free pre-print version: Loading...

      Abstract: Publication date: July 2021Source: The Lancet Oncology, Volume 22, Issue 7Author(s): The Lancet Oncology
       
  • The International Collaboration for Research methods Development in
           Oncology (CReDO) workshops: shaping the future of global oncology research
           

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 30 June 2021Source: The Lancet OncologyAuthor(s): Priya Ranganathan, Girish Chinnaswamy, Manju Sengar, Durga Gadgil, Shivakumar Thiagarajan, Balram Bhargava, Christopher M Booth, Marc Buyse, Sanjiv Chopra, Chris Frampton, Satish Gopal, Nick Grant, Mark Krailo, Ruth Langley, Prashant Mathur, Xavier Paoletti, Mahesh Parmar, Arnie Purushotham, Douglas Pyle, Preetha Rajaraman
       
  • Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed
           malignant glioma: a first-in-human, phase 1, dose-escalation trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 29 June 2021Source: The Lancet OncologyAuthor(s): Jawad Fares, Atique U Ahmed, Ilya V Ulasov, Adam M Sonabend, Jason Miska, Catalina Lee-Chang, Irina V Balyasnikova, James P Chandler, Jana Portnow, Matthew C Tate, Priya Kumthekar, Rimas V Lukas, Sean A Grimm, Ann K Adams, Charles D Hébert, Theresa V Strong, Christina Amidei, Victor A Arrieta, Markella Zannikou, Craig Horbinski
       
  • Hitchhiking to brain tumours: stem cell delivery of oncolytic viruses

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 29 June 2021Source: The Lancet OncologyAuthor(s): Juan Fueyo, Candelaria Gomez-Manzano, Frederick F Lang, Marta M Alonso
       
  • Improving single-agent chemoresistance risk identification in gestational
           trophoblastic neoplasia

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 25 June 2021Source: The Lancet OncologyAuthor(s): Gabriella Ferrandina, Giovanni Scambia
       
  • Predictors for single-agent resistance in FIGO score 5 or 6 gestational
           trophoblastic neoplasia: a multicentre, retrospective, cohort study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 25 June 2021Source: The Lancet OncologyAuthor(s): Antonio Braga, Gabriela Paiva, Ehsan Ghorani, Fernanda Freitas, Luis Guillermo Coca Velarde, Baljeet Kaur, Nick Unsworth, Jingky Lozano-Kuehne, Ana Paula Vieira dos Santos Esteves, Jorge Rezende Filho, Joffre Amim, Xianne Aguiar, Naveed Sarwar, Kevin M Elias, Neil S Horowitz, Ross S Berkowitz, Michael J Seckl
       
  • Getting back on track with HPV vaccination to prevent cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 24 June 2021Source: The Lancet OncologyAuthor(s): Manjulika Das
       
  • COVID-19 pandemic causes cervical cancer screening crisis

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 24 June 2021Source: The Lancet OncologyAuthor(s): Elizabeth Gourd
       
  • Camrelizumab versus placebo in combination with gemcitabine and cisplatin
           as first-line treatment for recurrent or metastatic nasopharyngeal
           carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3
           trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 23 June 2021Source: The Lancet OncologyAuthor(s): Yunpeng Yang, Song Qu, Jingao Li, Chaosu Hu, Mingjun Xu, Weidong Li, Ting Zhou, Liangfang Shen, Hui Wu, Jinyi Lang, Guangyuan Hu, Zhanxiong Luo, Zhichao Fu, Shenhong Qu, Weineng Feng, Xiaozhong Chen, Shaojun Lin, Weimin Zhang, Xiaojiang Li, Yan Sun
       
  • Lenvatinib plus pembrolizumab in patients with either treatment-naive or
           previously treated metastatic renal cell carcinoma (Study
           111/KEYNOTE-146): a phase 1b/2 study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 15 June 2021Source: The Lancet OncologyAuthor(s): Chung-Han Lee, Amishi Yogesh Shah, Drew Rasco, Arpit Rao, Matthew H Taylor, Christopher Di Simone, James J Hsieh, Alvaro Pinto, David R Shaffer, Regina Girones Sarrio, Allen Lee Cohn, Nicholas J Vogelzang, Mehmet Asim Bilen, Sara Gunnestad Ribe, Musaberk Goksel, Øyvind Krohn Tennøe, Donald Richards, Randy F Sweis, Jay Courtright, Daniel Heinrich
       
  • Avelumab alone or in combination with chemotherapy versus chemotherapy
           alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN
           Ovarian 200): an open-label, three-arm, randomised, phase 3 study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 15 June 2021Source: The Lancet OncologyAuthor(s): Eric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A Ledermann, Amit M Oza, Rebecca Kristeleit, Isabelle-Laure Ray-Coquard, Gary E Richardson, Cristiana Sessa, Kan Yonemori, Susana Banerjee, Alexandra Leary, Anna V Tinker, Kyung Hae Jung, Radoslaw Madry, Sang-Yoon Park, Charles K Anderson, Fabian Zohren, Ross A Stewart, Caimiao Wei, Samuel S Dychter
       
  • Immunotherapy in ovarian cancer: we are not there yet

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 15 June 2021Source: The Lancet OncologyAuthor(s): Emma Barber, Daniela Matei
       
  • Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in
           unresectable hepatocellular carcinoma (ORIENT-32): a randomised,
           open-label, phase 2–3 study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 15 June 2021Source: The Lancet OncologyAuthor(s): Zhenggang Ren, Jianming Xu, Yuxian Bai, Aibing Xu, Shundong Cang, Chengyou Du, Qiu Li, Yinying Lu, Yajin Chen, Yabing Guo, Zhendong Chen, Baorui Liu, Weidong Jia, Jian Wu, Junye Wang, Guoliang Shao, Bixiang Zhang, Yunfeng Shan, Zhiqiang Meng, Jianbing Wu
       
  • Greater price transparency needed for thyroid cancer treatment among US
           cancer centres

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 11 June 2021Source: The Lancet OncologyAuthor(s): Mary Beth Nierengarten
       
  • Spinal stereotactic radiotherapy for painful spinal metastasis

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 11 June 2021Source: The Lancet OncologyAuthor(s): Joanne M van der Velden, Yvette M van der Linden
       
  • Stereotactic body radiotherapy versus conventional external beam
           radiotherapy in patients with painful spinal metastases: an open-label,
           multicentre, randomised, controlled, phase 2/3 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 11 June 2021Source: The Lancet OncologyAuthor(s): Arjun Sahgal, Sten D Myrehaug, Shankar Siva, Giuseppina L Masucci, Pejman J Maralani, Michael Brundage, James Butler, Edward Chow, Michael G Fehlings, Mathew Foote, Zsolt Gabos, Jeffrey Greenspoon, Marc Kerba, Young Lee, Mitchell Liu, Stanley K Liu, Isabelle Thibault, Rebecca K Wong, Maaike Hum, Keyue Ding
       
  • 2021 ASCO Virtual Annual Meeting

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 10 June 2021Source: The Lancet OncologyAuthor(s): Márcia Costa
       
  • Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a
           multi-cohort, open-label, phase 1/2 study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 9 June 2021Source: The Lancet OncologyAuthor(s): Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe A Cassier, Gilberto Lopes, Daniel S W Tan, Elena Garralda, Luis G Paz-Ares, Byoung Chul Cho, Shirish M Gadgeel, Michael Thomas, Stephen V Liu, Matthew H Taylor, Aaron S Mansfield, Viola W Zhu, Corinne Clifford
       
  • A step closer to a personalised approach for Lynch syndrome

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 7 June 2021Source: The Lancet OncologyAuthor(s): Veroushka Ballester
       
  • Variation in the risk of colorectal cancer in families with Lynch
           syndrome: a retrospective cohort study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 7 June 2021Source: The Lancet OncologyAuthor(s): Aung Ko Win, James G. Dowty, Jeanette C. Reece, Grant Lee, Allyson S. Templeton, John-Paul Plazzer, Daniel D. Buchanan, Kiwamu Akagi, Seçil Aksoy, Angel Alonso, Karin Alvarez, David J. Amor, Ravindran Ankathil, Stefan Aretz, Julie L. Arnold, Melyssa Aronson, Rachel Austin, Ann-Sofie Backman, Sanne W. Bajwa-ten Broeke, Verónica Barca-Tierno
       
  • UK Government urged to recognise post-COVID-19 cancer backlog

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 3 June 2021Source: The Lancet OncologyAuthor(s): Emma Wilkinson
       
  • Calls to scale up international funding for tobacco control

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 3 June 2021Source: The Lancet OncologyAuthor(s): Talha Khan Burki
       
  • COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Peter A Prieto, Kathleen Mannava, Deepak M Sahasrabudhe
       
  • 8th European Conference on Infections in Leukaemia: 2020 guidelines for
           the use of antibiotics in paediatric patients with cancer or
           post-haematopoietic cell transplantation

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Thomas Lehrnbecher, Dina Averbuch, Elio Castagnola, Simone Cesaro, Roland A Ammann, Carolina Garcia-Vidal, Jukka Kanerva, Fanny Lanternier, Alessio Mesini, Malgorzata Mikulska, Dorothea Pana, Nicole Ritz, Monica Slavin, Jan Styczynski, Adilia Warris, Andreas H Groll, 8th European Conference on Infections in Leukaemia
       
  • 8th European Conference on Infections in Leukaemia: 2020 guidelines for
           the diagnosis, prevention, and treatment of invasive fungal diseases in
           paediatric patients with cancer or post-haematopoietic cell
           transplantation

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Andreas H Groll, Dorothea Pana, Fanny Lanternier, Alessio Mesini, Roland A Ammann, Dina Averbuch, Elio Castagnola, Simone Cesaro, Dan Engelhard, Carolina Garcia-Vidal, Jukka Kanerva, Nicole Ritz, Emmanuel Roilides, Jan Styczynski, Adilia Warris, Thomas Lehrnbecher, 8th European Conference on Infections in Leukaemia
       
  • The effect of non-AIDS-defining cancers on people living with HIV

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Elizabeth Y Chiao, Anna Coghill, Darya Kizub, Valeria Fink, Ntokozo Ndlovu, Angela Mazul, Keith Sigel
       
  • Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and
           dexamethasone alone in previously treated multiple myeloma (APOLLO): an
           open-label, randomised, phase 3 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tahamtan Ahmadi, Jon Ukropec, Tobias Kampfenkel, Jordan M Schecter, Yanping Qiu, Himal Amin
       
  • Safety and immunogenicity of one versus two doses of the COVID-19 vaccine
           BNT162b2 for patients with cancer: interim analysis of a prospective
           observational study

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Leticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, Duncan R McKenzie, Irene del Molino del Barrio, Thanussuyah Alaguthurai, Clara Domingo-Vila, Thomas S Hayday, Carl Graham, Jeffrey Seow, Sultan Abdul-Jawad, Shraddha Kamdar, Elizabeth Harvey-Jones, Rosalind Graham, Jack Cooper, Muhammad Khan, Jennifer Vidler, Helen Kakkassery, Shubhankar Sinha, Richard Davis
       
  • Difficulties accessing cancer care in the Gaza Strip

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Manjulika Das
       
  • Higher fatality from COVID-19 in patients with cancer in the UK than in
           Europe

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Flávia Oliveira Geraldes
       
  • Correction to Lancet Oncol 2021; 22: 872–82

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s):
       
  • Correction to Lancet Oncol 2021; 22: 678–89

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s):
       
  • Correction to Lancet Oncol 2021; 22: 309–20

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s):
       
  • Adjuvant immunotherapy in muscle-invasive urothelial carcinoma –
           Author's reply

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Joaquim Bellmunt
       
  • Adjuvant immunotherapy in muscle-invasive urothelial carcinoma

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Alessandro Rizzo, Veronica Mollica, Francesco Massari
       
  • Adjuvant immunotherapy in muscle-invasive urothelial carcinoma

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Satoshi Funada, Yan Luo
       
  • Pembrolizumab for relapsed or refractory Hodgkin lymphoma – Author's
           reply

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): John Kuruvilla, KEYNOTE-204 investigators
       
  • Pembrolizumab for relapsed or refractory Hodgkin lymphoma

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Alessandro Pulsoni
       
  • Secondary cytoreduction for relapsed ovarian cancer – Authors' reply

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Yulian Chen, Tingyan Shi, Jihong Liu, Jianqing Zhu, Rongyu Zang
       
  • Secondary cytoreduction for relapsed ovarian cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: June 2021Source: The Lancet Oncology, Volume 22, Issue 6Author(s): Giovanni Maria Iannantuono, Elena Giudice
       
  • Gauging the quality-of-life benefits of immunotherapy in hepatocellular
           carcinoma

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 27 May 2021Source: The Lancet OncologyAuthor(s): Nicola Personeni, Lorenza Rimassa
       
  • Impact of COVID-19 on cancer care in India: a cohort study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 27 May 2021Source: The Lancet OncologyAuthor(s): Priya Ranganathan, Manju Sengar, Girish Chinnaswamy, Gaurav Agrawal, Rajkumar Arumugham, Rajiv Bhatt, Ramesh Bilimagga, Jayanta Chakrabarti, Arun Chandrasekharan, Harit Kumar Chaturvedi, Rajiv Choudhrie, Mitali Dandekar, Ashok Das, Vineeta Goel, Caleb Harris, Sujai Kolnadguthu Hegde, Narendra Hulikal, Deepa Joseph, Rajesh Kantharia, Azizullah Khan
       
  • Patient-reported outcomes with atezolizumab plus bevacizumab versus
           sorafenib in patients with unresectable hepatocellular carcinoma
           (IMbrave150): an open-label, randomised, phase 3 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 27 May 2021Source: The Lancet OncologyAuthor(s): Peter R Galle, Richard S Finn, Shukui Qin, Masafumi Ikeda, Andrew X Zhu, Tae-You Kim, Masatoshi Kudo, Valeriy Breder, Philippe Merle, Ahmed Kaseb, Daneng Li, Sohail Mulla, Wendy Verret, Derek-Zhen Xu, Sairy Hernandez, Beiying Ding, Juan Liu, Chen Huang, Ho Yeong Lim, Ann-Lii Cheng
       
  • Pembrolizumab alone or combined with chemotherapy versus chemotherapy as
           first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a
           randomised, open-label, phase 3 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 26 May 2021Source: The Lancet OncologyAuthor(s): Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Y-S Cheng, Yves Fradet, Stephane Oudard, Christof Vulsteke, Rafael Morales Barrera, Aude Fléchon, Seyda Gunduz, Yohann Loriot, Alejo Rodriguez-Vida, Ronac Mamtani, Evan Y Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva
       
  • Chemoimmunotherapy in urothelial cancer: concurrent or sequential'

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 26 May 2021Source: The Lancet OncologyAuthor(s): Zeynep B Zengin, Luis Meza, Sumanta K Pal, Petros Grivas
       
  • Pembrolizumab monotherapy for the treatment of high-risk
           non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an
           open-label, single-arm, multicentre, phase 2 study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 26 May 2021Source: The Lancet OncologyAuthor(s): Arjun V Balar, Ashish M Kamat, Girish S Kulkarni, Edward M Uchio, Joost L Boormans, Mathieu Roumiguié, Laurence E M Krieger, Eric A Singer, Dean F Bajorin, Petros Grivas, Ho Kyung Seo, Hiroyuki Nishiyama, Badrinath R Konety, Haojie Li, Kijoeng Nam, Ekta Kapadia, Tara Frenkl, Ronald de Wit
       
  • Colorectal cancer screening in Europe: what are the next steps'

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 25 May 2021Source: The Lancet OncologyAuthor(s): Ismail Gogenur, Camilla Qvortrup
       
  • Colorectal cancer incidence, mortality, and stage distribution in European
           countries in the colorectal cancer screening era: an international
           population-based study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 25 May 2021Source: The Lancet OncologyAuthor(s): Rafael Cardoso, Feng Guo, Thomas Heisser, Monika Hackl, Petra Ihle, Harlinde De Schutter, Nancy Van Damme, Zdravka Valerianova, Trajan Atanasov, Ondřej Májek, Jan Mužík, Mef Christina Nilbert, Anne Julie Tybjerg, Kaire Innos, Margit Mägi, Nea Malila, Anne-Marie Bouvier, Véronique Bouvier, Guy Launoy, Anne-Sophie Woronoff
       
  • The concept and use of the neoadjuvant rectal score as a composite
           endpoint in rectal cancer

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 25 May 2021Source: The Lancet OncologyAuthor(s): Robert Glynne-Jones, Stuart Glynne-Jones
       
  • Chemotherapy de-escalation using an 18F-FDG-PET-based pathological
           response-adapted strategy in patients with HER2-positive early breast
           cancer (PHERGain): a multicentre, randomised, open-label, non-comparative,
           phase 2 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 18 May 2021Source: The Lancet OncologyAuthor(s): José Manuel Pérez-García, Geraldine Gebhart, Manuel Ruiz Borrego, Agostina Stradella, Begoña Bermejo, Peter Schmid, Frederik Marmé, Santiago Escrivá-de-Romani, Lourdes Calvo, Nuria Ribelles, Noelia Martinez, Cinta Albacar, Aleix Prat, Florence Dalenc, Khaldoun Kerrou, Marco Colleoni, Noemia Afonso, Serena Di Cosimo, Miguel Sampayo-Cordero, Andrea Malfettone
       
  • Neoadjuvant durvalumab with or without stereotactic body radiotherapy in
           patients with early-stage non-small-cell lung cancer: a single-centre,
           randomised phase 2 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 18 May 2021Source: The Lancet OncologyAuthor(s): Nasser K Altorki, Timothy E McGraw, Alain C Borczuk, Ashish Saxena, Jeffrey L Port, Brendon M Stiles, Benjamin E Lee, Nicholas J Sanfilippo, Ronald J Scheff, Bradley B Pua, James F Gruden, Paul J Christos, Cathy Spinelli, Joyce Gakuria, Manik Uppal, Bhavneet Binder, Olivier Elemento, Karla V Ballman, Silvia C Formenti
       
  • WHO publishes framework for safe and affordable surgery in Western Pacific
           countries

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 14 May 2021Source: The Lancet OncologyAuthor(s): Emma Wilkinson
       
  • Updated recommendations regarding the management of older patients with
           breast cancer: a joint paper from the European Society of Breast Cancer
           Specialists (EUSOMA) and the International Society of Geriatric Oncology
           (SIOG)

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 14 May 2021Source: The Lancet OncologyAuthor(s): Laura Biganzoli, Nicolò Matteo Luca Battisti, Hans Wildiers, Amelia McCartney, Giuseppe Colloca, Ian H Kunkler, Maria-João Cardoso, Kwok-Leung Cheung, Nienke Aafke de Glas, Rubina M Trimboli, Beatriz Korc-Grodzicki, Enrique Soto-Perez-de-Celis, Antonio Ponti, Janice Tsang, Lorenza Marotti, Karen Benn, Matti S Aapro, Etienne G C Brain
       
  • Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic
           glioma (CATNON; EORTC study 26053-22054): second interim analysis of a
           randomised, open-label, phase 3 study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 14 May 2021Source: The Lancet OncologyAuthor(s): Martin J van den Bent, C Mircea S Tesileanu, Wolfgang Wick, Marc Sanson, Alba Ariela Brandes, Paul M Clement, Sarah Erridge, Michael A Vogelbaum, Anna K Nowak, Jean Français Baurain, Warren P Mason, Helen Wheeler, Olivier L Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain
       
  • Cemiplimab in locally advanced basal cell carcinoma after hedgehog
           

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 14 May 2021Source: The Lancet OncologyAuthor(s): Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Martin Kaatz, Karl D Lewis, Nicole Basset-Seguin, Anne Lynn S Chang, Stèphane Dalle, Almudena Fernandez Orland, Lisa Licitra, Caroline Robert, Claas Ulrich, Axel Hauschild, Michael R Migden, Reinhard Dummer, Siyu Li, Suk-Young Yoo, Kosalai Mohan
       
  • Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible
           patients with advanced urothelial carcinoma (EV‑201): a multicentre,
           single-arm, phase 2 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 12 May 2021Source: The Lancet OncologyAuthor(s): Evan Y Yu, Daniel P Petrylak, Peter H O'Donnell, Jae-Lyun Lee, Michiel S van der Heijden, Yohann Loriot, Mark N Stein, Andrea Necchi, Takahiro Kojima, Michael R Harrison, Se Hoon Park, David I Quinn, Elisabeth I Heath, Jonathan E Rosenberg, Joyce Steinberg, Shang-Ying Liang, Janet Trowbridge, Mary Campbell, Bradley McGregor, Arjun V Balar
       
  • Pembrolizumab plus cetuximab in patients with recurrent or metastatic head
           and neck squamous cell carcinoma: an open-label, multi-arm,
           non-randomised, multicentre, phase 2 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 11 May 2021Source: The Lancet OncologyAuthor(s): Assuntina G Sacco, Ruifeng Chen, Francis P Worden, Deborah J L Wong, Douglas Adkins, Paul Swiecicki, Wanxing Chai-Ho, Peter Oppelt, Debanjali Ghosh, Julie Bykowski, Alfredo Molinolo, Emily Pittman, M Valeria Estrada, Kathryn Gold, Gregory Daniels, Scott M Lippman, Amanda Natsuhara, Karen Messer, Ezra E W Cohen
       
  • Loncastuximab tesirine in relapsed or refractory diffuse large B-cell
           lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 11 May 2021Source: The Lancet OncologyAuthor(s): Paolo F Caimi, Weiyun Ai, Juan Pablo Alderuccio, Kirit M Ardeshna, Mehdi Hamadani, Brian Hess, Brad S Kahl, John Radford, Melhem Solh, Anastasios Stathis, Pier Luigi Zinzani, Karin Havenith, Jay Feingold, Shui He, Yajuan Qin, David Ungar, Xiaoyan Zhang, Carmelo Carlo-Stella
       
  • Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with
           metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre,
           retrospective, cohort study

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 11 May 2021Source: The Lancet OncologyAuthor(s): Ines Pires da Silva, Tasnia Ahmed, Irene L M Reijers, Alison M Weppler, Allison Betof Warner, James Randall Patrinely, Patricio Serra-Bellver, Clara Allayous, Joanna Mangana, Khang Nguyen, Lisa Zimmer, Claudia Trojaniello, Dan Stout, Megan Lyle, Oliver Klein, Camille L Gerard, Olivier Michielin, Andrew Haydon, Paolo A Ascierto, Matteo S Carlino
       
  • Conflicts of interest in tobacco industry-funded research

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 6 May 2021Source: The Lancet OncologyAuthor(s): Talha Khan Burki
       
  • Biden determined to “end cancer as we know it”

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 6 May 2021Source: The Lancet OncologyAuthor(s): Elizabeth Gourd
       
  • Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing
           metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label,
           phase 2 trial

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 4 May 2021Source: The Lancet OncologyAuthor(s): Salvatore Siena, Maria Di Bartolomeo, Kanwal Raghav, Toshiki Masuishi, Fotios Loupakis, Hisato Kawakami, Kensei Yamaguchi, Tomohiro Nishina, Marwan Fakih, Elena Elez, Javier Rodriguez, Fortunato Ciardiello, Yoshito Komatsu, Taito Esaki, Ki Chung, Zev Wainberg, Andrea Sartore-Bianchi, Kapil Saxena, Eriko Yamamoto, Emarjola Bako
       
  • Correction to Lancet Oncol 2021; 22: 581–83

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 30 April 2021Source: The Lancet OncologyAuthor(s):
       
  • Petition to ban nicotine pouches in Kenya

    • Free pre-print version: Loading...

      Abstract: Publication date: Available online 29 April 2021Source: The Lancet OncologyAuthor(s): Talha Khan Burki
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.237.16.210
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-